id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_lbjz23isnfbh5bcl4jbmahp6r4	Milica Popovic	The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome	2020	9	.pdf	application/pdf	6169	668	54	We investigated in two studies whether copeptin levels – the surrogate marker for AVP – are regulated by IL-1-mediated chronic inflammation in patients with inflammation is associated with increased circulating copeptin levels, antagonizing IL-1 does not significantly alter copeptin levels in patients with metabolic syndrome. HbA1c levels in patients with type 2 diabetes mellitus copeptin observed in patients with metabolic syndrome are To assess treatment effects on copeptin levels, we used were adjusted for baseline copeptin levels, treatment day, median copeptin levels for patients without diabetes were in baseline copeptin levels between the two treatment high copeptin levels with the metabolic syndrome. AVP/copeptin levels in patients with metabolic syndrome. copeptin levels in patients with metabolic syndrome. copeptin levels in patients with metabolic syndrome. Change in Copeptin levels from baseline according to treatment group abstract reporting study results on copeptin levels before Effect of IL-1 receptor antagonism on copeptin levels	./cache/work_lbjz23isnfbh5bcl4jbmahp6r4.pdf	./txt/work_lbjz23isnfbh5bcl4jbmahp6r4.txt